Subsidiaries and Technologies

Technologies and Equity Investment

Quest is an Alberta based biotechnology company developing and commercializing products to improve the quality of life.

Targeted Cancer Therapy: MAb AR9.6

  • US territory licensed to Oncocare Therapeutics
  • MAb AR9.6 against truncated MUC 16 for pancreatic cancer

Mutant EGF for Dermatology and Wound Healing

  • Licensed from Stanford University
  • Target indication: Wound healing

Quest has Equity Investment in the following companies